Vasa Denticity
- Market cap
- ₹ 787 Cr.
- P/E
- 67.9x
- P/B
- 4.53x
- 52-week range
- 322.5 – 616
- ROE
- 7%
- ROCE
- 9%
- Dividend yield
- 0%
- Debt / equity
- 0
- Sector
- Healthcare Equipment & Supplies
- Industry
- Medical Equipment & Supplies
- Listed on
- NSE SME
About
Vasa Denticity Limited is an India-based company, which is engaged in supplying a range of dental products, instruments, equipment, and consumables to dental clinics, hospitals, and practitioners across India. It provides comprehensive dental commerce and technology platforms, purpose-built to serve the full spectrum of needs for oral-care professionals. The Company offers over 22,000 dental products and has onboarding of approximately 468 brands. It provides Nasal Drops/Spray, Local Anesthesia, Analgesics, Antipyretics & Anti-Inflammatory, Vitamins & Supplements, Antibiotics. Its brands are OrthoMetric, GC, Dentsply, Waldent, SuperEndo, Waldent AlChem, ET Dental, Mani, GDC, Woodpecker. Its subsidiaries include Waldent Innovations Private Limited and Smileworks Private Limited. The Company is engaged in the business of manufacturing, processing, exporting, importing, distributing, and trading a range of surgical instruments, diagnostic equipment, and medical devices.
Quick check
The five things to look at first. Open one for more.
Compared with its industry
Medical Equipment & Supplies: 25 companies →Vasa Denticity against the typical company in its industry. The rank is out of the companies that report each figure; green means the better quarter of the pack, red the worse quarter.
- Valuation (P/E)67.9 against a typical 26.9: pricier than most peers (1st = cheapest).22nd of 25
- Sales growth+36.9% against a typical +21.5% from a year earlier.6th of 18
- Profit growth+46% against a typical +13.4% from a year earlier.4th of 16
- Share price, 3 months−0.6% against a typical −7.9%.8th of 23
- Size₹ 787.4 Cr. market value against a typical ₹ 238.1 Cr. (1st = largest).8th of 24
Credit ratings
Every rating action on file, newest first, including reaffirmations. Open a row for the agency's reasoning. All credit rating updates
Moderate safety, with caution
Rated BBB by CRISIL- No warnings from the agency.
| Agency | Current rating | Outlook | As of |
|---|---|---|---|
| CRISIL | Crisil BBB | Stable | 4 Jun 2026 |
| Rating | Details | |||||
|---|---|---|---|---|---|---|
| 4 Jun 2026 | Reaffirmed | Crisil BBB/Watch Developing → Crisil BBB | — | CRISIL | ₹ 15 Cr. | |
| 6 May 2026 | Reaffirmed | Crisil BBB/Watch Developing | — | CRISIL | ₹ 15 Cr. | |
| 5 Feb 2026 | Reaffirmed | Crisil BBB/Watch Developing | — | CRISIL | ₹ 15 Cr. | |
| 7 Nov 2025 | Reaffirmed | Crisil BBB/Watch Developing | — | CRISIL | ₹ 15 Cr. | |
| 12 Aug 2025 | Rating action | Crisil BBB/Watch Developing | — | CRISIL | ₹ 15 Cr. |
Board meetings
Results dates and other board meetings. Full calendar
| Details | ||
|---|---|---|
| 7 Aug 2026 | Financial Results | To consider and approve the financial results for the period ended Jun 30, 2026 |
| 26 May 2026 | Financial Results | To consider and approve the financial results for the period ended March 31, 2026 |
| 11 Nov 2025 | Financial Results | To consider and approve the financial results for the quarter and half year ended September 30, 2025 |
| 14 Aug 2025 | Board Meeting Intimation | VASA DENTICITY LIMITED has informed the Exchange about Board Meeting to be held on 14-Aug-2025 to inter-alia consider and approve the Unaudited Financial results of the Company for the Quarterly ended June 2025 . |
| 1 Aug 2025 | Other business matters | To consider other business matters |
| 16 May 2025 | Financial Results | To consider and approve the financial results for the quarter and financial year ended March 31, 2025 |
Financials
Consolidated figures in ₹ crore.
| ₹ Cr. | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 41 | 37 | 57 | 54 | 59 | 63 | 73 | 60 | 73 | 71 | 72 | 82 |
| Expenses | 37 | 33 | 49 | 49 | 53 | 57 | 66 | 57 | 67 | 70 | 72 | 77 |
| Operating Profit | 4 | 3 | 8 | 5 | 6 | 6 | 7 | 3 | 6 | 2 | 0 | 5 |
| OPM % | 8.8% | 9.4% | 14.3% | 8.7% | 10.8% | 8.8% | 9% | 5.3% | 8.4% | 2.6% | 0.3% | 6.2% |
| Other Income | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 1 | 1 | 1 | 2 | 1 |
| Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Depreciation | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 0 | 0 | 1 | 1 | 1 |
| Profit before tax | 4 | 3 | 8 | 5 | 7 | 5 | 6 | 4 | 6 | 2 | 2 | 5 |
| Tax % | 16.7% | 29.4% | 23.6% | 25.6% | 24.4% | 27.2% | 29.8% | 25.8% | 21.9% | 25.7% | 19.2% | 20.9% |
| Net Profit | 4 | 2 | 6 | 3 | 5 | 4 | 4 | 3 | 5 | 2 | 1 | 4 |
| EPS in Rs | 2.33 | 1.53 | 3.96 | 2.14 | 3.35 | 2.4 | 2.6 | 1.73 | 2.88 | 0.9 | 0.78 | 2.42 |
Growth and returns
Compounded yearly rates over each period.
- 10 Years
- —
- 5 Years
- 47%
- 3 Years
- 31%
- TTM
- 17%
- 10 Years
- —
- 5 Years
- 101%
- 3 Years
- 12%
- TTM
- −27%
- 10 Years
- —
- 5 Years
- —
- 3 Years
- −5%
- TTM
- —
- 10 Years
- —
- 5 Years
- 18%
- 3 Years
- 14%
- TTM
- —
P/E and EPS over time
Daily P/E and trailing 12-month EPS. EPS updates with each result.
Peers
Listed companies in the same business.
| Vasa Denticity | ₹ 410.55 | ₹ 787 Cr. | 67.9x | 4.5x | 7% | — |
| Lenskart Solutions | ₹ 627.55 | ₹ 1,08,959 Cr. | 181x | 10.7x | 6.7% | 5.7% |
| Poly Medicure | ₹ 1,446.80 | ₹ 14,582 Cr. | 52.1x | 5.5x | 11% | 17.1% |
| Laxmi Dental | ₹ 171.25 | ₹ 946 Cr. | 35.6x | 5x | 12.8% | 9.5% |
| One Global Service Provider | ₹ 372.00 | ₹ 721 Cr. | 17x | 8.3x | 65.2% | 14% |
| Mallcom (India) | ₹ 909.00 | ₹ 567 Cr. | 21.9x | 2.1x | 9.7% | 5.6% |
Management
- Vikas Agarwal
- Chairman of the Board, Founder, Managing Director
- Sandeep Aggarwal
- Co-Founder, Chief Operating Officer, Whole Time Director
- Nidhi Sharma
- Compliance Officer, Company Secretary
Prices are delayed and for information only. Nothing on this page is investment advice.